Eisai; Pfizer Inc

Majority of Physicians,(1) Alzheimer’s Disease (AD) Carers(1) and the General Public(1) in Five European Countries Understand the Need to Detect and Treat AD Early, Yet the Disease Remains Significantly Under-Diagnosed(2)

Older News

VIENNA - - Attitudinal and Behavioural Barriers(1) - Combined with Inability to Recognize Disease Symptoms(1) - Contribute to Delay in Diagnosis and Treatment A new study presented today at a major International medical meeting reveals that approximately two-thirds of physicians in the United Kingdom, France, Italy, Spain and Germany agree that Alzheimer's disease (AD) is under-diagnosed(1) and under-treated,(1) and explains how physicians, carers and the general population share responsibility in the issue.

MORE..